|

Technetium [99mTc]-H7ND injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.1

Indications

  • Peritoneal Metastasis1
  • Solid Tumor1
  • Cancer1

Other1 trial

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.